A S Garden

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy
    Adam S Garden
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 85:941-7. 2013
  2. pmc Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century
    Adam S Garden
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Radiat Oncol 8:21. 2013
  3. pmc Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer
    Emily Neubauer
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiat Oncol 7:19. 2012
  4. doi request reprint Head and neck radiation and mucositis
    Adam S Garden
    Departments of Radiation Oncology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Support Palliat Care 1:30-4. 2007
  5. ncbi request reprint Mucositis: current management and investigations
    Adam S Garden
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Radiat Oncol 13:267-73. 2003
  6. ncbi request reprint Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 55:322-8. 2003
  7. ncbi request reprint Organ preservation for carcinoma of the larynx and hypopharynx
    A S Garden
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Hematol Oncol Clin North Am 15:243-60, v. 2001
  8. ncbi request reprint Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:1171-8. 2004
  9. ncbi request reprint Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck
    A S Garden
    Department of Radiation Oncology, Unit 97, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 22:2856-64. 2004
  10. ncbi request reprint How to reduce radiation-related toxicity in patients with cancer of the head and neck
    Adam S Garden
    Department of Radiation Oncology and Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston TX, 77030, USA
    Curr Oncol Rep 8:140-5. 2006

Collaborators

Detail Information

Publications76

  1. doi request reprint Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy
    Adam S Garden
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 85:941-7. 2013
    ..To report mature results of a large cohort of patients diagnosed with squamous cell carcinoma of the oropharynx who were treated with intensity modulated radiation therapy (IMRT)...
  2. pmc Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century
    Adam S Garden
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Radiat Oncol 8:21. 2013
    ..We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches...
  3. pmc Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer
    Emily Neubauer
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiat Oncol 7:19. 2012
    ..The purpose of this study was to determine the interfractional displacement of the shoulders relative to isocenter over the course of treatment and the associated dosimetric effect of this displacement...
  4. doi request reprint Head and neck radiation and mucositis
    Adam S Garden
    Departments of Radiation Oncology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Curr Opin Support Palliat Care 1:30-4. 2007
    ..We will review the recent literature that has provided new insights into the pathogenesis, metrics and therapeutics of mucositis...
  5. ncbi request reprint Mucositis: current management and investigations
    Adam S Garden
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Semin Radiat Oncol 13:267-73. 2003
    ....
  6. ncbi request reprint Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 55:322-8. 2003
    ..This retrospective study updated the results of RT for patients treated at our center. The primary focus of this study was whether a policy of using hyperfractionated RT for these patients resulted in a therapeutic gain...
  7. ncbi request reprint Organ preservation for carcinoma of the larynx and hypopharynx
    A S Garden
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Hematol Oncol Clin North Am 15:243-60, v. 2001
    ..Both retrospective experiences and randomized trials evaluating differing therapies in an effort to achieve voice preservation are reported and analyzed...
  8. ncbi request reprint Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:1171-8. 2004
    ....
  9. ncbi request reprint Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck
    A S Garden
    Department of Radiation Oncology, Unit 97, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 22:2856-64. 2004
    ..To define further the role of concurrent chemoradiotherapy for patients with advanced squamous carcinoma of the head and neck...
  10. ncbi request reprint How to reduce radiation-related toxicity in patients with cancer of the head and neck
    Adam S Garden
    Department of Radiation Oncology and Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston TX, 77030, USA
    Curr Oncol Rep 8:140-5. 2006
    ..Minimizing radiation dose to these tissues may lower the incidence of radiation-induced dysphagia...
  11. ncbi request reprint Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma
    Adam S Garden
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 67:438-44. 2007
    ....
  12. ncbi request reprint Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses
    A S Garden
    Departments of Radiation Oncology, Thoracic Head and Neck Medical Oncology, and Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 17:2390-5. 1999
    ....
  13. ncbi request reprint A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
    K K Fu
    Department of Radiation Oncology, University of California San Francisco, 94143 0226, USA
    Int J Radiat Oncol Biol Phys 48:7-16. 2000
    ..The objective of this randomized trial was to test the efficacy of hyperfractionation and two types of accelerated fractionation individually against standard fractionation...
  14. ncbi request reprint Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer
    K K Ang
    Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 51:571-8. 2001
    ..These findings emphasize the importance of coordinated interdisciplinary care in the delivery of combined surgery and RT...
  15. ncbi request reprint Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial
    D M Shin
    Departments of Thoracic Head and Neck Medical Oncology, Diagnostic Imaging, Head and Neck Surgery, Biostatistics, Radiation Oncology, and Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 19:3010-7. 2001
    ..We designed the present phase II adjuvant trial to prevent recurrence or second primary tumors (SPTs) using 13-cRA, IFN-alpha, and alpha-tocopherol in locally advanced-stage head and neck cancer...
  16. ncbi request reprint Postoperative radiotherapy for malignant tumors of the submandibular gland
    M R Storey
    Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 51:952-8. 2001
    ..In the current series, locoregional control rates for high-risk patients with submandibular gland cancers treated with surgery and postoperative radiotherapy were excellent, with an actuarial locoregional control rate of 88% at 10 years...
  17. ncbi request reprint Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
    N R Schechter
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 51:4-9. 2001
    ..The purpose of this review is to assess the potential contribution of FDG-PET scans to the treatment of head-and-neck cancer patients...
  18. doi request reprint Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer
    S S Yom
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    AJNR Am J Neuroradiol 32:1532-8. 2011
    ..The purpose of this study was to evaluate the utility of US, with or without FNA, in regard to the postradiotherapy effects on documented metastatic adenopathy in patients with oropharyngeal cancer...
  19. ncbi request reprint Altered fractionation for head and neck cancer
    A S Garden
    Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA
    Oncology (Williston Park) 15:1326-32, 1334; discussion 1334, 1339-41. 2001
    ..This randomized trial of more than 1,000 patients addressed various fractionation schedules proposed to improve results for head and neck cancer patients treated with radiation...
  20. doi request reprint Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings
    J M Debnam
    Department of Radiology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    AJNR Am J Neuroradiol 29:558-62. 2008
    ..The purpose of this study was to review CT imaging findings of soft tissue mucosal ulceration in patients following radiation treatment for head and neck malignancies and to correlate these with patient outcomes...
  21. ncbi request reprint Radiotherapy for head and neck cancer
    D L Schwartz
    Department of Radiation Oncology, M D Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Hematol Oncol Clin North Am 20:259-85. 2006
    ..Continued dedication and work on the part of provider and patient alike will be required to make this promise a reality...
  22. ncbi request reprint TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
    Lancet Oncol 8:613-24. 2007
    ....
  23. ncbi request reprint Combination of radiotherapy with EGFR antagonists for head and neck carcinoma
    Juliette Thariat
    Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Clin Oncol 12:99-110. 2007
    ....
  24. ncbi request reprint Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
    Mark S Chambers
    Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 69:1369-76. 2007
    ..To assess the safety of long-term cevimeline treatment of radiation-induced xerostomia in patients with head-and-neck cancer; and to assess the efficacy of cevimeline in these patients...
  25. ncbi request reprint Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment
    Ian J Bristol
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:719-30. 2007
    ..To determine the effects of three changes in radiotherapy technique on the outcomes for patients irradiated postoperatively for maxillary sinus cancer...
  26. ncbi request reprint Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module
    David I Rosenthal
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Head Neck 29:923-31. 2007
    ....
  27. ncbi request reprint The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy
    David I Rosenthal
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 30:191-8. 2007
    ..To investigate interobserver variability in the delineation of head-and-neck (H&N) anatomic structures on CT images, including the effects of image artifacts and observer experience...
  28. ncbi request reprint The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers
    Michael E Kupferman
    Department of Head and Neck Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77096, USA
    Cancer 109:2052-7. 2007
    ..To further explore its therapeutic benefit in the management of head and neck squamous cell carcinoma, the authors reviewed their experience utilizing IBT at the M. D. Anderson Cancer Center...
  29. ncbi request reprint Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1110-20. 2007
    ..To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM) among patients receiving radiotherapy (RT) to head and neck primary cancers...
  30. ncbi request reprint Intensity-modulated radiation therapy and xerostomia
    Mark S Chambers
    Department of Head and Neck Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Calif Dent Assoc 34:743-8. 2006
    ....
  31. ncbi request reprint Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14
    K Kian Ang
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
    J Clin Oncol 23:3008-15. 2005
    ..To investigate the feasibility of combining concomitant boost accelerated radiation regimen (AFX-C) with cisplatin and to assess its toxicity and the relapse pattern and survival in patients with advanced head and neck carcinoma (HNC)...
  32. ncbi request reprint Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry and Chicago Cancer Center, University of Illinois, Chicago, Illinois 60612, USA
    Cancer 109:1914-22. 2007
    ..The OMWQ-HN is a patient-reported outcome questionnaire that measures the symptoms of mucositis, including mouth and throat soreness (MTS), and their impact on patient well-being and function...
  33. ncbi request reprint Outcomes after radiotherapy for squamous cell carcinoma of the eyelid
    Janjira Petsuksiri
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:111-8. 2008
    ..Squamous cell carcinoma (SCC) of the eyelid is a rare malignancy with metastatic potential. In the current study, the outcomes of patients with SCC of the eyelid were evaluated after definitive and postoperative radiation therapy...
  34. doi request reprint Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy
    Grace L Smith
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 26:5119-25. 2008
    ..Cerebrovascular disease is common in head and neck cancer patients, but it is unknown whether radiotherapy increases the cerebrovascular disease risk in this population...
  35. pmc Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method
    He Wang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 72:210-9. 2008
    ..The goal of this study was to quantitatively evaluate the performance of the algorithm in typical clinical applications...
  36. doi request reprint Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation
    Mark S Chambers
    Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Prosthet Dent 100:142-6. 2008
    ..Determining the impact that salivary sediments have on measured salivary flow rates during radiation is important for management of patients...
  37. pmc Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:1351-5. 2008
    ..This article reports the long-term toxicity, relapse patterns, and survival in patients with advanced head and neck carcinoma...
  38. doi request reprint Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis
    Mitchell Machtay
    Jefferson Medical College and Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA, USA
    J Clin Oncol 26:3582-9. 2008
    ..This study evaluates clinical factors that are associated with and might predict severe late toxicity after CCRT...
  39. doi request reprint Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study
    Juliette Thariat
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:2698-709. 2008
    ..Its poorer prognosis compared with common SCC remains controversial. The authors investigated the outcomes of patients with BSCC who received radiotherapy and compared them with the outcomes of patients with SCC...
  40. doi request reprint Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era
    David L Schwartz
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Head Neck 30:883-8. 2008
    ..The purpose of this study is to catalog modern-era postoperative radiotherapy (external beam radiotherapy [EBRT]) outcomes for advanced medullary thyroid cancer...
  41. pmc Long-term radiotherapy outcomes for nasal cavity and septal cancers
    Matthew W Allen
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:401-6. 2008
    ..Carcinoma of the nasal cavity and septum has historically been associated with a poor prognosis. This report updates the long-term outcomes for radiotherapy (RT) of this disease site at the University of Texas M.D. Anderson Cancer Center...
  42. ncbi request reprint Psychosocial and economic impact of cancer
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, TX 77030, USA
    Dent Clin North Am 52:231-52, x. 2008
    ....
  43. ncbi request reprint Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study"
    Mark S Chambers
    Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
    Oral Oncol 43:98-105. 2007
    ..It would be more convenient than the daily home application of a tray of 0.4% stannous fluoride or 1.1% sodium fluoride gel, and avoids the problem of variable patient compliance...
  44. pmc Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?
    Jennifer C O'Daniel
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 69:1290-6. 2007
    ..To quantify the differences between planned and delivered parotid gland and target doses, and to assess the benefits of daily bone alignment for head and neck cancer patients treated with intensity-modulated radiotherapy (IMRT)...
  45. ncbi request reprint Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis
    Farzan Siddiqui
    Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA
    Int J Radiat Oncol Biol Phys 70:353-60. 2008
    ....
  46. ncbi request reprint Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck
    Anne S Tsao
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 24:4163-9. 2006
    ....
  47. ncbi request reprint Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides
    Mark S Chambers
    Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
    Oral Oncol 42:934-45. 2006
    ..Part 1 discusses the historical and currently available fluoride preparations and Part 2 presents data of a recently completed trial investigating the benefit of an intraoral sodium fluoride releasing system...
  48. ncbi request reprint Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management
    Mark S Chambers
    Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
    Head Neck 26:796-807. 2004
    ..Xerostomia is a common, debilitating complication of radiation therapy (RT) for head and neck cancer. This article reviews the pathogenesis of radiation-induced xerostomia, its impact on quality of life (QOL), and treatment options...
  49. ncbi request reprint Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system
    Jerry L Barker
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 59:960-70. 2004
    ..We conducted a pilot study to quantify the magnitude of these anatomic changes with systematic CT imaging...
  50. ncbi request reprint New equations for matching a low neck field to oblique upper neck fields with collimator rotation in a 3-field monoisocentric setup for head-and-neck cancers
    Maria A Manske
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Med Dosim 29:86-91. 2004
    ..They predict the necessary manipulations of the LAN boost field to maintain a geometrically precise matchline, as verified by 3D treatment planning software, phantom dosimetry, and actual patient setups...
  51. ncbi request reprint Radiation therapy for early-stage carcinoma of the oropharynx
    Ugur Selek
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, 77030, USA
    Int J Radiat Oncol Biol Phys 59:743-51. 2004
    ....
  52. ncbi request reprint Target coverage for head and neck cancers treated with IMRT: review of clinical experiences
    Adam S Garden
    Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Semin Radiat Oncol 14:103-9. 2004
    ..This review will focus on how IMRT is being implemented into the treatment of head and neck cancer, specifically with regards to target definition and dosing issues...
  53. ncbi request reprint Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients
    Hee Kyun Oh
    Department of Oral and Maxillofacial Surgery, College of Dentistry, Chonnam National University, South Korea
    J Oral Maxillofac Surg 62:139-44. 2004
    ..This study was performed to compare the risk of osteoradionecrosis (ORN) in head and neck cancer patients in whom 1 or more impacted third molars were extracted before radiotherapy with patients whose impacted third molars were left intact...
  54. ncbi request reprint Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck
    Mark D Bonnen
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 100:383-9. 2004
    ..Toxicity was also assessed...
  55. ncbi request reprint Where are the at-risk cervical nodes?
    Adam S Garden
    Int J Radiat Oncol Biol Phys 58:1-2. 2004
  56. ncbi request reprint Management of nonsinonasal neuroendocrine carcinomas of the head and neck
    Jerry L Barker
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:2322-8. 2003
    ..The authors undertook a retrospective study to gain insights into the spectrum of clinicopathologic characteristics, patterns of failure, and optimal management of patients with this disease...
  57. ncbi request reprint Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma
    Vassiliki A Papadimitrakopoulou
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:2214-23. 2003
    ....
  58. ncbi request reprint Adjuvant irradiation for cervical lymph node metastases from melanoma
    Matthew T Ballo
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas77030, USA
    Cancer 97:1789-96. 2003
    ..The risk of regional disease recurrence after surgery alone for lymph node metastases from melanoma is well documented. The role of adjuvant irradiation remains controversial...
  59. ncbi request reprint Adult rhabdomyosarcoma: outcome following multimodality treatment
    Darren J Little
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:377-88. 2002
    ..Childhood rhabdomyosarcoma (RMS) has a relatively good prognosis. Outcome for adults with this disease is poorly documented due to its rarity...
  60. ncbi request reprint Electron conformal radiotherapy using bolus and intensity modulation
    Rajat J Kudchadker
    Department of Radiation Physics, M D Anderson Cancer Center, University of Texas, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 53:1023-37. 2002
    ..The present work evaluates the ability to restore dose homogeneity by varying the incident electron intensity...
  61. ncbi request reprint Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype
    David I Rosenthal
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 101:2567-73. 2004
    ..The authors reviewed their institutional experience to determine whether sinonasal neuroendocrine tumors of different histologies have distinct clinical characteristics that warrant individualized treatment approaches...
  62. ncbi request reprint Is there still a role for induction chemotherapy for head and neck cancer?
    Adam S Garden
    J Clin Oncol 23:1059-60. 2005
  63. ncbi request reprint Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer
    Sue S Yom
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:469-76. 2006
    ..This report compares the clinical outcomes of patients treated with postoperative radiation (PORT) using either 3FT or CTT...
  64. ncbi request reprint Importance of patient examination to clinical quality assurance in head and neck radiation oncology
    David I Rosenthal
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Head Neck 28:967-73. 2006
    ..We determined the value of clinical peer review in radiation therapy for head and neck cancer that involved head and neck examination...
  65. ncbi request reprint Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study
    Mark S Chambers
    Department of Head and Neck Surgery, Department of Radiation Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
    Oral Oncol 42:946-53. 2006
    ..It would be more convenient than the daily home application of a tray of 0.4% stannous fluoride or 1.1% sodium fluoride gel, and avoids the problem of variable patient compliance...
  66. ncbi request reprint Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13
    Elizabeth A Elliott
    Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 24:2092-7. 2006
    ..This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating institution for patients with head and neck cancer undergoing radiation therapy...
  67. ncbi request reprint Impact of changes to the American Joint Committee on Cancer T classification on outcome prediction in patients with oropharyngeal cancer
    Joshua A Asper
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:1950-7. 2006
    ..The efficacy of the current 6th edition of the American Joint Committee on Cancer (AJCC) tumor staging criteria in improving outcome prediction for patients with oropharyngeal cancer was analyzed...
  68. ncbi request reprint Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy
    Lifei Zhang
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 64:1559-69. 2006
    ..To analyze three-dimensional setup uncertainties for multiple regions of interest (ROIs) in head-and-neck region...
  69. ncbi request reprint Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes
    Smith Apisarnthanarax
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 64:678-83. 2006
    ..To determine the optimal clinical target volume margins around the gross nodal tumor volume in head-and-neck cancer by assessing microscopic tumor extension beyond cervical lymph node capsules...
  70. ncbi request reprint Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue
    Bradley A Schiff
    Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    Arch Otolaryngol Head Neck Surg 131:874-8. 2005
    ....
  71. ncbi request reprint A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma
    Faye M Johnson
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:717-24. 2005
    ..This strategy was based on theoretical radiosensitization with chemotherapy during accelerated repopulation of the tumor with relatively radioresistant clonogens...
  72. ncbi request reprint Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
    Matthew T Ballo
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Head Neck 27:718-21. 2005
    ..Completion cervical lymphadenectomy is usually performed after excisional biopsy of nodal metastases from melanoma. Radiation (XRT) might be effective for some patients in lieu of formal lymph node dissection...
  73. ncbi request reprint Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants
    David G Kornguth
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 62:665-71. 2005
    ..We hypothesized that two ERCC4 single-nucleotide polymorphisms are associated with normal-tissue toxicity in patients treated with radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC)...
  74. ncbi request reprint Intensity-modulated radiotherapy: is xerostomia still prevalent?
    Mark S Chambers
    Department of Head and Neck Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
    Curr Oncol Rep 7:131-6. 2005
    ....
  75. ncbi request reprint A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma
    Vincent Gregoire
    Department of Radiation Oncology, Universite Catholique de Louvain, St Luc University Hospital, 10 Avenue Hippocrate, Brussels, Belgium
    Radiother Oncol 63:187-93. 2002
    ..D. Anderson Cancer Center in Houston, and the other conducted in two Belgian hospitals) exploring concurrent fludarabine and radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinomas (HNSCC)...
  76. ncbi request reprint Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy
    He Wang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Phys Med Biol 50:2887-905. 2005
    ..Together, these results suggest that the accelerated demons algorithm has significant potential for delineating and tracking doses in targets and critical structures during CT-guided radiotherapy...